LIVER METASTASES
Clinical trials for LIVER METASTASES explained in plain language.
Never miss a new study
Get alerted when new LIVER METASTASES trials appear
Sign up with your email to follow new studies for LIVER METASTASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR therapy targets Hard-to-Treat lung cancer liver tumors
Disease control Not yet recruitingThis early-stage study tests a new gene-editing drug called EDB-102 in 15 adults with advanced non-small cell lung cancer that has spread to the liver and is no longer responding to standard targeted therapy. The drug uses CRISPR technology to find and disable a specific cancer-c…
Matched conditions: LIVER METASTASES
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New hope for Hard-to-Treat colorectal cancer: immunotherapy before surgery
Disease control Not yet recruitingThis study tests whether giving immunotherapy before surgery can help people with a certain type of colorectal cancer that has spread to the liver. The cancer is called microsatellite stable (MSS), which usually does not respond well to immunotherapy. About 24 adults will receive…
Matched conditions: LIVER METASTASES
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
SAMe supplement may shield liver from chemo damage
Prevention Not yet recruitingThis study tests whether taking S-adenosylmethionine (SAMe), a common supplement, can prevent liver injury caused by the chemotherapy drug oxaliplatin in people with colorectal cancer that has spread to the liver. About 30 participants will take SAMe pills daily for 3-6 months al…
Matched conditions: LIVER METASTASES
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Prevention
Last updated May 17, 2026 02:06 UTC
-
New test could warn of pancreatic Cancer's return
Knowledge-focused Not yet recruitingThis study looks at whether tumor cells found in the portal vein (a major liver blood vessel) can help predict if pancreatic cancer will come back or spread after surgery. Researchers will collect these cells during an endoscopic ultrasound and combine them with other tests. The …
Matched conditions: LIVER METASTASES
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 17, 2026 02:01 UTC
-
1,000 patients to be tracked after liver surgery in new observational study
Knowledge-focused Not yet recruitingThis study will follow 1,000 adults who have liver or bile duct surgery at San Jacopo Hospital in Pistoia. Researchers will track complications, survival, and cancer recurrence for up to 5 years. The goal is to better understand how patients recover and their long-term outcomes a…
Matched conditions: LIVER METASTASES
Sponsor: Azienda USL Toscana Centro • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC